Device typePostmeiotic segregation increased 2 (PMS2) IVD, antibody: One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of postmeiotic segregation increased 2 (PMS2), a DNA mismatch repair protein, in a clinical specimen.
FDA categoryImmunohistochemistry test, DNA mismatch repair (MMR) Protein assay
Device ID05700575005244
MRI safetyLabeling does not contain MRI Safety Information
Total Volume12 Milliliter